Netherlands Wound Care Management Devices Market Size and Share

Netherlands Wound Care Management Devices Market (2025 - 2030)
View Global Report

Netherlands Wound Care Management Devices Market Analysis by Mordor Intelligence

The Netherlands wound care management devices market size was valued at USD 220.46 million in 2025 and estimated to grow from USD 231.24 million in 2026 to reach USD 293.62 million by 2031, at a CAGR of 4.89% during the forecast period (2026-2031). Demand growth is fueled by a rising elderly population, wider use of negative-pressure and sensor-enabled therapies, and the national Fast-Track protocol that has compressed specialist referral times and redirected resources toward higher-value technologies. Hospitals are moving from volume-based purchasing to outcome-focused procurement, prompting manufacturers to emphasize total cost-of-care propositions rather than product features. Retail channels are gaining traction as self-management products and e-commerce platforms make professional-grade dressings accessible to patients. Sustainability mandates, especially restrictions on single-use plastics, are accelerating innovation in bio-based materials and encouraging circular business models for devices and packaging.

Key Report Takeaways

  • By product, wound care devices led with 67.02% of the Netherlands wound care management devices market share in 2025, while wound closure products are forecast to grow at 5.11% CAGR through 2031.  
  • By wound type, chronic wounds accounted for 60.42% of the Netherlands wound care management devices market size in 2025, but acute wounds represent the fastest growth at 5.55% CAGR to 2031.  
  • By end user, hospitals and specialty clinics held 50.20% of the Netherlands wound care management devices market share in 2025; home healthcare settings exhibit the highest projected CAGR at 5.58% through 2031.  
  • By mode of purchase, institutional procurement captured 62.71% of the Netherlands wound care management devices market size in 2025, whereas retail and OTC channels are advancing at 5.72% CAGR to 2031.  

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.

Segment Analysis

By Product: Broad Device Portfolios Command the Premium Tier

Wound care devices retained 67.02% share of the Netherlands wound care management devices market in 2025, led by foam dressings, hydrofibers, and negative-pressure platforms that provide superior exudate management and infection control. Smith+Nephew’s NPWT line contributed to 3.8% underlying revenue growth in its Advanced Wound Management division during Q1 2025. Clinical studies that position advanced dressings as cost-neutral over an episode of care are sustaining hospital demand even amid reimbursement scrutiny. Wound closure products account for smaller revenue but are expanding at 5.11% CAGR as staplers, sealants, and bioabsorbable clips gain favor in minimally invasive surgery. Sensor-integrated dressings that transmit temperature or pH data to clinicians are blurring category boundaries, enabling hybrid products that both close and monitor wounds.  

The Netherlands wound care management devices market size for wound closure solutions is set to climb as procedure volumes rise and surgeons seek devices that limit operative time while improving cosmetic results. Incorporation of antimicrobial coatings into sutures is lowering post-operative infection risk, aligning with hospital quality metrics. Biodegradable adhesives promise avoidance of removal procedures, adding patient convenience. In parallel, developers are embedding microelectronics into adhesives to create intelligent closures capable of reporting tension or moisture in real time, a capability valued by surgical teams pursuing enhanced recovery protocols.

Netherlands Wound Care Management Devices Market: Market Share by Product, 2025
Netherlands Wound Care Management Devices Market: Market Share by Product, 2025

By Wound Type: Chronic-Care Complexity Sustains Advanced Therapy Demand

Chronic wounds captured 60.42% of Netherlands wound care management devices market share in 2025, reflecting the cumulative effects of aging, vascular disease, and diabetes. Prevalence of pressure ulcers in institutionalized elderly patients drives perpetual consumption of foam and antimicrobial dressings, while NPWT shortens closure timelines for recalcitrant diabetic ulcers. Frailty assessments reveal higher-than-expected care complexity, necessitating technologies that simplify dressing changes and enable caregivers with limited wound expertise. The Netherlands wound care management devices market size for chronic wounds is projected to grow steadily as the population aged 65 + rises and comorbid conditions accumulate.

Acute wounds are forecast to expand faster at 5.55% CAGR, riding on surgical volume growth and improved trauma survival rates. Prophylactic NPWT has demonstrated infection reductions of more than 50% in complex abdominal procedures, encouraging routine use in high-risk surgeries. Burns treatment for older adults remains resource-intensive, reinforcing demand for dressings that speed re-epithelialization while minimizing pain. The Netherlands wound care management devices industry increasingly couples acute-wound therapies with digital monitoring, allowing early intervention when complications emerge.

By End User: Home Healthcare Emergence Reshapes Care Delivery

Hospitals and specialty clinics retained 50.20% revenue share in 2025, yet the home-care channel grows 5.58% CAGR as digital monitoring underpins safe decentralisation. Luscii’s remote-care platform has already lowered cardiology outpatient visits by 19%; OMRON’s January-2025 takeover signals strategic intent to embed similar functionality in wound care workflows. Portable NPWT units approved for patient self-management enable same-day discharge, lowering inpatient bed-days and amplifying Netherlands wound care management devices market penetration beyond hospital walls.

Institutional facilities remain indispensable for complex or surgically intensive cases. AI-powered imaging tools have analysed 50 million wounds to date, supplying clinicians with healing-trajectory forecasts that refine treatment choice. As ageing deepens, long-term-care operators pilot sensor carpets and chair-pressure maps that alert nurses to shear or moisture risk, integrating wound prevention into everyday elder care.

Netherlands Wound Care Management Devices Market: Market Share by End User, 2025
Netherlands Wound Care Management Devices Market: Market Share by End User, 2025

By Mode of Purchase: Retail Growth Signals Patient Empowerment

Institutional procurement contributed 62.71% of 2025 revenue, mirroring strict professional oversight for advanced modalities. Value-based tenders now score bids on healing time, total cost and environmental footprint, lifting barriers for suppliers ready with lifecycle analyses. The Fast-Track protocol standardises triage, nudging GPs toward products with published algorithms and validated outcomes.

Retail and OTC channels climb at 5.72% CAGR as educated patients order silicagel sheets, hydrocolloids and smart dressings through e-commerce. Integrated tele-consultation services help customers photograph wounds and receive guidance, reinforcing adherence while shrinking travel costs. This consumer pivot enlarges the Netherlands wound care management devices market and forces manufacturers to package professional-grade performance in user-friendly formats.

Geography Analysis

Urban teaching hospitals in Amsterdam, Utrecht, and Rotterdam spearhead adoption of advanced wound care systems, enabled by research grants and robust clinical-trial infrastructure. These centers often pilot smart dressings and predictive analytics platforms before nationwide rollout, anchoring early revenue streams for innovators. Rural regions, by contrast, face shortages of certified wound-care nurses, prompting investment in telehealth to bridge expertise gaps. Implementation of the Fast-Track referral model nationwide has harmonized treatment pathways, yet rural clinics still confront longer travel times for specialist consultations, reinforcing the appeal of home-based NPWT units.

Government funding of EUR 600 million to expand nursing-home capacity beginning 2027 will concentrate new demand for institutional wound-care technologies outside the Randstad corridor. Facilities built under this program are being designed with sensor-enabled care suites, positioning them as early adopters of continuous monitoring systems. Recycling mandates appear most stringent in university hospitals, where sustainability offices track packaging waste as a procurement criterion, indirectly shaping supplier portfolios. Cross-border care agreements with Germany and Belgium facilitate knowledge exchange and joint clinical studies, benefiting Dutch suppliers that can prove efficacy in broader European populations.

The Netherlands wound care management devices market registers near-uniform reimbursement rules across provinces, yet local procurement collaboratives negotiate separate supply contracts that favor vendors able to guarantee just-in-time logistics. The national electronic-health-record backbone simplifies data collection for outcomes-based purchasing, giving device makers that offer integrated digital dashboards an advantage. Overall, regulatory coherence, high digital maturity, and demographic headwinds combine to create a fertile test bed for novel wound-management ecosystems.

Regulatory Landscape

Wound care management devices in the Netherlands are regulated under the EU Medical Device Regulation (MDR) 2017/745 (in force since May 26, 2021) and implemented nationally through the Wet medische hulpmiddelen and related implementing measures.

The Inspectie Gezondheidszorg en Jeugd (IGJ) is the primary supervisory authority, monitoring compliance across the device lifecycle for manufacturers, importers and distributors, including vigilance and market surveillance activities. Market access requirements include conformity assessment and CE marking, traceability and operator obligations aligned to the EU framework, and operator registration via EUDAMED, alongside Dutch-specific registration routes (for example, Farmatec/NOTIS where applicable). IGJ enforcement powers include administrative measures and fines that can reach EUR 450,000 under the Medical Devices Act framework, and it applies an MDR/IVDR intervention policy that prioritizes remediation while keeping risk-based oversight of non-conformities.

Competitive Landscape

Multinational incumbents such as Smith+Nephew, ConvaTec, and Mölnlycke hold leading positions in the Netherlands wound care management devices market by coupling broad portfolios with established key-account teams. Smith+Nephew’s RENASYS EDGE rollout and 3.8% Q1 2025 revenue uptick demonstrate the resilience of premium NPWT lines. ConvaTec’s 2024 clinical study results showcased faster closure for its collagen-alginate dressings, reinforcing evidence-based marketing tactics. Mölnlycke leverages its Safetac silicone technology to secure formularies that prioritize atraumatic dressing removal.

Digital-health entrants, often spin-outs from Dutch universities, target gaps in real-time monitoring and predictive analytics. Plasmacure’s cold-plasma PLASOMA device, able to close wounds 2.5 times faster in clinical studies, positions the firm as a challenger with a differentiated modality. The acquisition of Luscii by OMRON Healthcare underscores rising interest from consumer-health giants in remote monitoring, potentially widening distribution channels for sensor-embedded dressings. Regulatory hurdles under the EU Medical Device Regulation favor well-capitalized players that can finance post-market surveillance and clinical evidence generation, but cloud-based software companies circumvent some hardware burdens, accelerating their go-to-market path.

Competitive battlegrounds increasingly coalesce around sustainability credentials and outcome-based pricing. Suppliers that reclaim NPWT pumps for refurbishment, or offer bio-based dressings that satisfy plastic-reduction targets, are gaining tender advantages. Hospitals award multi-year contracts contingent on healing-rate guarantees, prompting vendors to bundle devices, consumables, and analytics in integrated platforms. White-space opportunities include machine-learning wound-scoring engines, compostable absorbent layers, and end-to-end logistics services that reduce caregiver workload while improving healing trajectories.

Netherlands Wound Care Management Devices Industry Leaders

  1. ConvaTec

  2. Smith & Nephew

  3. Medtronic

  4. Solventum

  5. Coloplast

  6. *Disclaimer: Major Players sorted in no particular order
nether.png

Market Opportunities and Future Outlook

Funding and partnership initiatives are shaping the Netherlands wound care landscape. In mid-2026, the Ministries of Health, Welfare and Sport (VWS) and Economic Affairs and Climate (EZK) announced EUR 102.5 million to strengthen the Dutch MedTech sector through 2036, with a requirement for at least matching private investment, and Philips committed EUR 50 million. This mix creates a platform for solutions that link wound care devices with outcomes data and clinical decision support.

On reimbursement and procurement, opportunities center on segments that can clear tighter qualification gates and document cost-effectiveness. NZa policy for complex wound care (regiefunctie complexe wondzorg) sets out a tariff framework for management, advice, and treatment of complex wounds, which supports organized care models when they are tied to measurable outcomes. At the channel level, insurer procurement requirements for 2026 for bandaging supplies (verbandmiddelen), including ISO certification, SEMH recognition, and BIG-registered wound nurses, favor suppliers that provide compliant service models, training, and documentation as part of a bundled offering rather than standalone products.

Recent Industry Developments

  • July 2026: A new regional guideline for complex wound care was developed for the Zuid-Holland Noord region, incorporating a wound indicator tool and decision flowcharts to standardize triage and treatment. The program also set out distribution of wound boxes to general practitioner practices from late September 2026, supporting protocol-driven consumption of appropriate dressings and devices closer to primary care.
  • May 2026: Philips committed EUR 50 million as part of the national funding backdrop to connect wound care devices with outcomes data and clinical decision support. It aligns with broader government and industry efforts to accelerate digital integration across hospital and community wound care pathways.
  • December 2024: UMC Utrecht and TU Delft unveiled WOCA, a low-cost portable NPWT device built on Arduino technology for trials in low-resource settings. The work points to ongoing innovation in portable negative pressure platforms and may influence future designs for more accessible wound care in resource-constrained environments.

Table of Contents for Netherlands Wound Care Management Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing incidence of chronic wounds & diabetic ulcers
    • 4.2.2 Rising surgical procedure volumes
    • 4.2.3 Rapidly expanding ageing population
    • 4.2.4 Uptake of negative-pressure & smart-sensor wound-therapy devices
    • 4.2.5 National Fast-Track protocol accelerating specialist referrals
    • 4.2.6 Sustainability push for bio-based, compostable dressings
  • 4.3 Market Restraints
    • 4.3.1 High total treatment cost for advanced modalities
    • 4.3.2 Stringent reimbursement approval in Dutch basic-insurance system
    • 4.3.3 Shortage of certified wound-care nurses
    • 4.3.4 Environmental restrictions on single-use plastics in hospitals
  • 4.4 Regulatory Landscape
  • 4.5 Technological Outlook
  • 4.6 Porters Five Forces Analysis
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product
    • 5.1.1 Wound Care
    • 5.1.1.1 Dressings
    • 5.1.1.1.1 Traditional Gauze & Tape Dressings
    • 5.1.1.1.2 Advanced Dressings
    • 5.1.1.2 Wound-Care Devices
    • 5.1.1.2.1 Negative Pressure Wound Therapy (NPWT)
    • 5.1.1.2.2 Oxygen & Hyperbaric Systems
    • 5.1.1.2.3 Electrical Stimulation Devices
    • 5.1.1.2.4 Other Wound Care Devices
    • 5.1.1.3 Other Wound Care Products
    • 5.1.2 Wound Closure
    • 5.1.2.1 Sutures
    • 5.1.2.2 Surgical Staplers
    • 5.1.2.3 Tissue Adhesives, Strips, Sealants & Glues
  • 5.2 By Wound Type
    • 5.2.1 Chronic Wounds
    • 5.2.1.1 Diabetic Foot Ulcer
    • 5.2.1.2 Pressure Ulcer
    • 5.2.1.3 Venous Leg Ulcer
    • 5.2.1.4 Other Chronic Wounds
    • 5.2.2 Acute Wounds
    • 5.2.2.1 Surgical/Traumatic Wounds
    • 5.2.2.2 Burns
    • 5.2.2.3 Other Acute Wounds
  • 5.3 By End User
    • 5.3.1 Hospitals & Specialty Wound Clinics
    • 5.3.2 Long-term Care Facilities
    • 5.3.3 Home-Healthcare Settings
  • 5.4 By Mode of Purchase
    • 5.4.1 Institutional Procurement
    • 5.4.2 Retail / OTC Channel

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Solventum
    • 6.3.2 Smith & Nephew plc
    • 6.3.3 Molnlycke Health Care AB
    • 6.3.4 B. Braun Melsungen AG
    • 6.3.5 ConvaTec Group plc
    • 6.3.6 Johnson & Johnson (Ethicon)
    • 6.3.7 Medtronic plc
    • 6.3.8 Lohmann & Rauscher GmbH
    • 6.3.9 Hollister Incorporated
    • 6.3.10 Integra LifeSciences
    • 6.3.11 Paul Hartmann AG
    • 6.3.12 Coloplast A/S
    • 6.3.13 Cardinal Health
    • 6.3.14 Urgo Medical
    • 6.3.15 Medela AG
    • 6.3.16 Essity (BSN medical)
    • 6.3.17 Organogenesis Inc.
    • 6.3.18 Stryker Corporation
    • 6.3.19 DermaRite Industries
    • 6.3.20 MiMedx Group
    • 6.3.21 DeRoyal Industries
    • 6.3.22 Bioventus LLC
    • 6.3.23 Kerecis Ehf.

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment

Research Methodology Framework and Report Scope

Market Definition and Coverage

For this study, the market covers revenues generated from wound care management devices used in the Netherlands across clinical and home care settings, where products are used to clean, protect, manage, or close acute and chronic wounds.

Scope exclusions: Over-the-counter first-aid plasters sold purely as consumer goods are not counted in this market size.

Segmentation Overview
  • By Product
    • Wound Care
      • Dressings
        • Traditional Gauze & Tape Dressings
        • Advanced Dressings
      • Wound-Care Devices
        • Negative Pressure Wound Therapy (NPWT)
        • Oxygen & Hyperbaric Systems
        • Electrical Stimulation Devices
        • Other Wound Care Devices
      • Other Wound Care Products
    • Wound Closure
      • Sutures
      • Surgical Staplers
      • Tissue Adhesives, Strips, Sealants & Glues
  • By Wound Type
    • Chronic Wounds
      • Diabetic Foot Ulcer
      • Pressure Ulcer
      • Venous Leg Ulcer
      • Other Chronic Wounds
    • Acute Wounds
      • Surgical/Traumatic Wounds
      • Burns
      • Other Acute Wounds
  • By End User
    • Hospitals & Specialty Wound Clinics
    • Long-term Care Facilities
    • Home-Healthcare Settings
  • By Mode of Purchase
    • Institutional Procurement
    • Retail / OTC Channel

Data Sources, Market Sizing, and Validation

Desk Research

Desk work starts by building a fact base for the Netherlands, so the sizing model is anchored in realistic care demand and supply availability. We rely on public sources such as the Dutch national statistics office, European health statistics, trade and customs releases, and peer-reviewed clinical and health-economics literature that describe treatment pathways and utilization patterns.

After that, the information is cross-checked using manufacturer annual reports and investor decks, product documentation published on official channels, and tender and procurement announcements, plus reputable medical device press coverage. Where needed, paid subscriptions for company financials and intelligence, patents, and shipment-level import and export signals help validate company presence and directional volumes without forcing the model to fit a desired curve. These examples are not exhaustive, and additional public references were used to collect data, confirm assumptions, and clarify gaps.

Primary Interviews and Surveys

Primary work is used to confirm what is actually purchased and used across hospitals, outpatient providers, and home care, and then to pressure-test pricing and adoption assumptions for different wound categories. We speak with manufacturers, distributors, clinicians, and procurement and reimbursement-linked stakeholders across the Netherlands, so the desk view can be adjusted where real-world purchasing and utilization differ.

Distribution of primary research fieldwork respondents

Company type Respondent position Region
Top tier: 32% CXOs: 17%
Mid tier: 47% Functional/Unit leaders: 29%
Smaller Players: 21% Managers: 54%

Market-Sizing & Forecasting

Sizing is built using a top-down approach where treated patient pools and procedure volumes are translated into product demand, and then converted into value using typical usage rates and average selling prices in the Netherlands. To keep the totals realistic, we corroborate results using selective bottom-up approximations, such as supplier and channel checks and sampled price per unit multiplied by estimated units, which are then used to adjust any large mismatches.

Key inputs for this market include the mix of chronic versus acute wounds treated, the split between hospital and home care and how that share shifts, adoption of negative pressure wound therapy systems for complex wounds, frequency of dressing changes by care setting, and price movements linked to procurement cycles and product mix (for example, advanced dressings versus basic options). When gaps appear in bottom-up checks, they are handled by using conservative ranges from interviews and by scaling smaller channels so they align with observed care volumes.

For forecasting, scenario analysis is used because demand can move with policy, staffing, and procurement decisions. Each scenario path is checked against the expected trajectory of wound prevalence and care setting shifts shared by industry experts. The final curve is reviewed year by year, so one-off shocks do not get treated as permanent changes.

Data Validation & Update Cycle

Validation is done in layers so errors are caught early and assumptions stay consistent. We compare the model output with independent signals such as treated population logic, procurement intensity, and the expected split between advanced modalities and standard care, and then rework any outliers until the story and the math align.

Before sign-off, the numbers go through variance checks across years, sensitivity checks on major inputs like usage rates and prices, and a second-analyst review for internal consistency. Reports are refreshed annually, and when major events occur (such as material pricing changes, reimbursement shifts, or procurement rule updates), assumptions are revisited and experts may be re-contacted. Right before delivery, a final pass is completed so clients receive the most current view available.

Mordor Intelligence's Netherlands Wound Care Management Devices Market Estimate Compared With Other Published Estimates

Published market values for wound care devices often do not match because scope choices and counting rules differ, and those differences can be hard to spot in headline numbers. The base year, the treatment of home care consumption, and whether adjacent wound closure products are bundled into the same category can all move the total.

In this market, the biggest gap drivers are usually whether first-aid consumer products are included, how negative pressure systems are valued (devices only versus devices plus consumables), and whether estimates assume aggressive adoption of advanced dressings versus a steadier mix. Currency conversion timing and how often the dataset is refreshed also matter, because Dutch procurement prices can change in steps rather than smoothly.

Benchmark comparison

Source Market Size Gaps in Research Methodology
Mordor Intelligence USD 220.46 M (2025)
Industry Research Publisher A USD 349.00 M (2023) Uses a broader product scope that explicitly bundles wound closure devices and bioengineered products, and the base year is earlier, which can lift totals if later price normalization is not applied.
Regional Insight Note B USD 349.55 M (2024) Represents a Benelux regional total rather than Netherlands-only demand, which can overstate the country market if the value is read as national and not adjusted for country split.

The spread in the table is mainly explained by scope and geography, rather than arithmetic mistakes, so the comparison should be read as like-for-like only after definitions are aligned. Excluding consumer-only first-aid plasters and keeping the count tied to Netherlands use, instead of rolling up Benelux or adjacent closure categories, is what holds the estimate to the intended demand pool in Mordor Intelligence.

Key Questions Answered in the Report

What is the current size of the Netherlands wound care management devices market?

The market stands at USD 231.24 million in 2026 and is set to reach USD 293.62 million by 2031.

Which product category holds the largest share?

Wound care devices, including advanced dressings and NPWT systems, hold 67.02% share of the Netherlands wound care management devices market.

How fast are home-healthcare applications growing?

Home-care use of wound devices is expanding at a 5.58% CAGR as telehealth and single-use NPWT enable safe treatment outside hospitals.

What is driving acute wound segment growth?

Rising surgical volumes and enhanced trauma care protocols are pushing the acute segment to a 5.55% CAGR through 2031.

How are sustainability rules affecting device procurement?

EU and Dutch bans on single-use plastics are pressuring hospitals to shift toward bio-based dressings and reusable NPWT pumps, reshaping supplier selection criteria.

Why are reimbursement approvals challenging for new devices?

The Dutch basic-insurance system demands strong clinical and economic evidence, extending timelines and raising the bar for advanced technologies seeking coverage.

Page last updated on:

Netherlands Wound Care Management Devices Market Report Snapshots